Praxis Precision Medicines, Inc. (PRAX) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-94.6%

$14.95

vs $276.54 price

Levered DCF

$15.87

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

96.13

Safe zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-21.86×	-7.54×	-1.19×	-0.51×	-5.01×	-7.97×	-1.2×	-1.36×
P/B	7.55×	3.09×	2.11×	1.44×	3.33×	1.71×	1.06×	2.46×
P/S	0×	161.13×	60.04×	0×	0×	0×	0×	0×
EV / EBITDA	-20.7×	-6.38×	-0.55×	-0.24×	-4.21×	-3.18×	0.02×	-0.69×
Gross margin	0.0%	-1682.0%	-3445.8%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	-2340.3%	-5164.4%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	-2137.5%	-5037.9%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	10.22×	10.77×	5.39×	3.23×	7.48×	19.23×	6.67×	3.72×
Debt / equity	0×	0×	0.04×	0.05×	0.02×	0×	0.04×	0×
Interest coverage	0×	0×	0×	0×	0×	0×	0×	-178.89×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-34.5%	-41.0%	-176.9%	-281.2%	-66.6%	-21.5%	-88.5%	-180.7%
Return on invested capital	-37.1%	-44.8%	-172.3%	-262.9%	-65.6%	-21.5%	-85.9%	-154.7%
Return on assets	-32.3%	-37.8%	-140.2%	-185.9%	-57.1%	-20.4%	-74.5%	-133.8%
Free cash flow yield	-3.8%	-9.6%	-75.7%	-169.1%	-15.0%	-10.7%	-77.3%	-57.6%
Earnings yield	-4.6%	-13.3%	-83.9%	-195.1%	-20.0%	-12.6%	-83.5%	-73.6%
Enterprise value	$6.3B	$1.2B	$68.1M	$51.6M	$702M	$196.6M	-$832.4K	$18.1M
Net debt / EBITDA	1.18×	1.17×	0.64×	0.27×	0.81×	4.78×	1.24×	0.68×
Cash conversion cycle (days)	-64,209	-30	-24	-35	0	0	-1,434	-1,237,715